Public health

FILE - In this Jan. 4, 2020, file photo, health surveillance officer use temperature scanner to monitor passengers arriving at the Hong Kong International airport in Hong Kong. The possibility that a new virus in central China could spread between humans cannot be ruled out, though the risk of transmission at the moment appears to be low, Chinese officials said Wednesday, Jan. 15, 2020. (AP Photo/Andy Wong, File)
January 15, 2020 - 5:00 am
BEIJING (AP) — The possibility that a new virus in central China could spread between humans cannot be ruled out, though the risk of transmission at the moment appears to be low, Chinese officials said Wednesday. Forty-one people in the city of Wuhan have received a preliminary diagnosis of a novel...
Read More
FILE - In this Jan. 4, 2020, file photo, health surveillance officer use temperature scanner to monitor passengers arriving at the Hong Kong International airport in Hong Kong. The possibility that a new virus in central China could spread between humans cannot be ruled out, though the risk of transmission at the moment appears to be low, Chinese officials said Wednesday, Jan. 15, 2020. (AP Photo/Andy Wong, File)
January 15, 2020 - 4:32 am
BEIJING (AP) — The possibility that a new virus in central China could spread between humans cannot be ruled out, though the risk of transmission at the moment appears to be low, Chinese officials said Wednesday. Forty-one people in the city of Wuhan have received a preliminary diagnosis of a novel...
Read More
January 15, 2020 - 4:09 am
BEIJING (AP) — The possibility that a new virus in central China could spread between humans cannot be ruled out, though the risk of transmission at the moment appears to be low, Chinese officials said Wednesday. Forty-one people in the city of Wuhan have received a preliminary diagnosis of a novel...
Read More
January 13, 2020 - 6:02 pm
BOSTON (AP) — A former executive for a drug company was sentenced Monday to 33 months in federal prison in a bribery and kickbacks scheme that Massachusetts prosecutors say helped fuel the national opioid epidemic. Michael Gurry, a former vice president at Insys Therapeutics, was also sentenced to...
Read More
Wong Ka-hing, the Controller of the Centre for Health Protection of the Department of Health holds a Wuhan Municipal Health Commission press statement of the new type of coronavirus, during a press conference at the Health Department in Hong Kong, Saturday, Jan. 11, 2020. Health authorities in the central Chinese city of Wuhan are reporting the first death from a new type of coronavirus. The Wuhan Municipal Health Commission reported Saturday that seven other people are in critical condition. (AP Photo/Andy Wong)
January 13, 2020 - 11:22 am
BANGKOK (AP) — A Chinese visitor to Thailand has been confirmed to be infected with a new strain of coronavirus that has been linked to a pneumonia outbreak in central China, health officials said Monday. The U.N.'s World Health Organization said Thai officials have reported that a traveler from...
Read More
January 13, 2020 - 11:00 am
GENEVA (AP) — The U.N. health agency said Monday that Thai officials have reported that a traveler from the Chinese city of Wuhan has been hospitalized in Thailand with a recently identified new type of coronavirus. The World Health Organization said Director-General Tedros Adhanom Ghebreyesus is...
Read More
FILE - In this Jan. 30, 2019, file photo, Insys Therapeutics founder John Kapoor leaves federal court in Boston. Kapoor and former top employees of the pharmaceutical company are facing a reckoning for their role in a bribery scheme that prosecutors say boosted sales of a powerful, highly addictive painkiller and helped fuel the national opioid epidemic. Starting Monday, Jan. 13, 2020, seven people who worked for Insys Therapeutics will appear in Boston to be sentenced by a federal judge. (AP Photo/Steven Senne, File)
January 12, 2020 - 3:27 pm
BOSTON (AP) — The founder and former top employees of a pharmaceutical company are facing a reckoning for their role in a bribery scheme that prosecutors say boosted sales of a powerful, highly addictive painkiller and helped fuel the national opioid epidemic. Starting Monday, seven people who...
Read More
FILE - In this Jan. 30, 2019, file photo, Insys Therapeutics founder John Kapoor leaves federal court in Boston. Kapoor and former top employees of the pharmaceutical company are facing a reckoning for their role in a bribery scheme that prosecutors say boosted sales of a powerful, highly addictive painkiller and helped fuel the national opioid epidemic. Starting Monday, Jan. 13, 2020, seven people who worked for Insys Therapeutics will appear in Boston to be sentenced by a federal judge. (AP Photo/Steven Senne, File)
January 12, 2020 - 3:26 pm
BOSTON (AP) — The founder and former top employees of a pharmaceutical company are facing a reckoning for their role in a bribery scheme that prosecutors say boosted sales of a powerful, highly addictive painkiller and helped fuel the national opioid epidemic. Starting Monday, seven people who...
Read More
FILE - This Sept. 2015, file image made from U.S. Border Patrol surveillance video shows a child crawling on the concrete floor near the bathroom area of a holding cell, and a woman and children wrapped in Mylar sheets at a U.S. Customs and Border Protection station in Douglas, Ariz. A years-old lawsuit challenging detention conditions in several of the Border Patrol’s Arizona stations will go to trial Monday, Jan. 13, 2020, as the agency as a whole has come under fire following several migrant deaths. The lawsuit was first filed in June 2015 and applies to eight Border Patrol facilities in Arizona where attorneys say migrants are held in unsafe and inhumane conditions. (U.S. Border Patrol via AP, File)
January 12, 2020 - 1:10 pm
PHOENIX (AP) — A years-old lawsuit challenging detention conditions in several of the Border Patrol’s Arizona stations will go to trial Monday as the agency as a whole has come under fire following several migrant deaths. The lawsuit filed in 2015 applies to eight Border Patrol facilities in...
Read More
FILE - In this Jan. 30, 2019, file photo, Insys Therapeutics founder John Kapoor leaves federal court in Boston. Kapoor and former top employees of the pharmaceutical company are facing a reckoning for their role in a bribery scheme that prosecutors say boosted sales of a powerful, highly addictive painkiller and helped fuel the national opioid epidemic. Starting Monday, Jan. 13, 2020, seven people who worked for Insys Therapeutics will appear in Boston to be sentenced by a federal judge. (AP Photo/Steven Senne, File)
January 12, 2020 - 11:55 am
BOSTON (AP) — The founder and former top employees of a pharmaceutical company are facing a reckoning for their role in a bribery scheme that prosecutors say boosted sales of a powerful, highly addictive painkiller and helped fuel the national opioid epidemic. Starting Monday, seven people who...
Read More

Pages